Literature DB >> 16079486

The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes.

Hyun-Jeong Cho1, Hyo-Chan Kang, Sun-A Choi, Young-Cheol Ju, Hyun-Sub Lee, Hwa-Jin Park.   

Abstract

Microsomal triglyceride (TG) transfer protein (MTP) is involved in the secretion of TG-rich very low-density lipoprotein (VLDL), a process which leads to the generation of hypertriglyceridemia and atherosclerosis. We investigated the possible role of Ca(2+) on MTP activity in hepatocytes. Exogenous CaCl(2) and calmodulin increased MTP activity dose-dependently, and calcium ionophore A23187 (A23187) also increased total Ca(2+) level and MTP activity in hepatocytes. Moreover, MTP activity increased by CaCl(2) or A23187 was abrogated in the presence of EDTA, a Ca(2+) chelator. MTP activity was increased by the simultaneous addition of CaCl(2) and calmodulin. However, this increase was inhibited by N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide (W-7), a Ca(2+) antagonist. A23187 increased the release of TG and cholesterol from hepatocytes, and these were inhibited by EDTA. A23187 also increased the ratio of TG to HDL-cholesterol in hepatocytes culture medium, which indicates the release of TG is higher than that of HDL-cholesterol from hepatocytes. Thus, our findings demonstrate that hepatocellular Ca(2+) contributes directly or indirectly to MTP activation. In conclusion, the inhibition of MTP activity via the suppression of hepatocellular Ca(2+) may result in the inhibition of hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16079486     DOI: 10.1248/bpb.28.1418

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  26 in total

1.  Effect of high-dose vitamin D supplementation on cardiometabolic risk factors in subjects with metabolic syndrome: a randomized controlled double-blind clinical trial.

Authors:  S Salekzamani; H Mehralizadeh; A Ghezel; Y Salekzamani; M A Jafarabadi; A S Bavil; B P Gargari
Journal:  J Endocrinol Invest       Date:  2016-07-11       Impact factor: 4.256

2.  Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women.

Authors:  Sara A Chacko; Yiqing Song; JoAnn E Manson; Linda Van Horn; Charles Eaton; Lisa W Martin; Anne McTiernan; J David Curb; Judith Wylie-Rosett; Lawrence S Phillips; Raymond A Plodkowski; Simin Liu
Journal:  Am J Clin Nutr       Date:  2011-05-25       Impact factor: 7.045

Review 3.  Causes of Vitamin D Deficiency and Effect of Vitamin D Supplementation on Metabolic Complications in Obesity: a Review.

Authors:  Louise Wamberg; Steen B Pedersen; Lars Rejnmark; Bjørn Richelsen
Journal:  Curr Obes Rep       Date:  2015-12

4.  Serum vitamin D and change in lipid levels over 5 y: The Atherosclerosis Risk in Communities study.

Authors:  Kamil F Faridi; Di Zhao; Seth S Martin; Joshua R Lupton; Steven R Jones; Eliseo Guallar; Christie M Ballantyne; Pamela L Lutsey; Erin D Michos
Journal:  Nutrition       Date:  2017-02-03       Impact factor: 4.008

5.  Effects of vitamin D on cardiovascular disease risk factors in polycystic ovary syndrome women with vitamin D deficiency.

Authors:  H Rahimi-Ardabili; B Pourghassem Gargari; L Farzadi
Journal:  J Endocrinol Invest       Date:  2012-03-22       Impact factor: 4.256

6.  Vitamin D deficiency is an independent predictor of elevated triglycerides in Spanish school children.

Authors:  Elena Rodríguez-Rodríguez; Rosa M Ortega; Liliana G González-Rodríguez; Ana M López-Sobaler
Journal:  Eur J Nutr       Date:  2010-11-20       Impact factor: 5.614

7.  Association of vitamin D and vitamin D receptor gene polymorphisms with chronic inflammation, insulin resistance and metabolic syndrome components in type 2 diabetic Egyptian patients.

Authors:  Amal M H Mackawy; Mohammed E H Badawi
Journal:  Meta Gene       Date:  2014-08-07

8.  Serum 25-hydroxyvitamin D, parathyroid hormone, and their association with metabolic syndrome in Chinese.

Authors:  Li-Hua Li; Xue-Yan Yin; Chao-Yong Yao; Xue-Chuang Zhu; Xin-Hua Wu
Journal:  Endocrine       Date:  2013-01-23       Impact factor: 3.633

9.  CD36 deletion reduces VLDL secretion, modulates liver prostaglandins, and exacerbates hepatic steatosis in ob/ob mice.

Authors:  Fatiha Nassir; Okunade L Adewole; Elizabeth M Brunt; Nada A Abumrad
Journal:  J Lipid Res       Date:  2013-08-20       Impact factor: 5.922

10.  Association between serum vitamin D, parathyroid hormone and metabolic syndrome in middle-aged and older Korean adults.

Authors:  J Kim
Journal:  Eur J Clin Nutr       Date:  2014-09-24       Impact factor: 4.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.